PPARA and atherosclerosis: PPARα and PPARγ catalysts could reduce inflammatory proteins such as adhesion molecules, cytokines, chemokines, in monocytes/macrophages, ECs and vascular smooth muscle cells.17 In addition, it has been revealed that PPAR activators can limit experimental atherosclerosis in animal models, although its expression is considered to be restricted to the tissues like liver and fat.18, 19